|  | Study period | |||
---|---|---|---|---|---|
Enrollment (-t1) | Allocation (0) | Post-allocation (t1-t12) | Close-out (t13) | ||
Assessment items (#) | Visit 1 (baseline, week 1) | Visit 2 (quit date, week 2) | Daily assessment (week 2 to 13) | Visit 3 (week 13) | |
Enrollment | |||||
 Eligibility screen |  | X |  |  |  |
 Informed consent |  | X |  |  |  |
 Allocation |  |  | X |  |  |
Interventions | |||||
 Short term incentives (6 weeks) |  | X | X | X | X |
 Long term incentives (12 weeks) |  | X | X | X | X |
 No incentives (control) |  | X | X | X | X |
Assessments | Â | Â | Â | Â | Â |
 Biological/anthropometric measures | 3 | X | X |  | X |
 Demographic/background information questionnaire | 10 | X |  |  |  |
Tobacco history questionnaire | 17 | X | Â | Â | Â |
Heaviness of smoking index | 2 | X | Â | Â | Â |
Wisconsin smoking withdrawal scale—craving (past week) | 4 | X |  |  |  |
Self-efficacy scale/confidence | 9 | X | Â | Â | Â |
Motivation to quit | 3 | X | Â | Â | Â |
Diabetes questionnaire | 5 | X | Â | Â | Â |
Diabetes self-management questionnaire | 16 | X | Â | Â | X |
Consideration of future consequences scale | 12 | X | Â | Â | Â |
Daily stress and anxiety | 5 | Â | Â | X | Â |
Daily urges to smoke | 4 | Â | Â | X | Â |
Daily mood and physical symptoms scale | 12 | Â | Â | X | Â |
Daily self-efficacy/confidence/motivation | 4 | Â | Â | X | Â |
Daily tobacco and medication use | 7 | Â | Â | X | Â |
Daily diabetes and health questions | 6 | Â | Â | X | Â |
Daily CO reading (iCO™ Smokerlyzer®) | 1 |  |  | X |  |
Study participation exit questionnaire | 10 | Â | Â | Â | X |